A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing

Kazuko Sakai1, Masayuki Takeda2, Shigeki Shimizu3

  • 1Department of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, 589-8511, Japan.

Scientific Reports
|August 7, 2019
PubMed

Insights

This study compared three knowledge-based curation systems for personalized cancer medicine. While all systems aided treatment decisions, Watson for Genomics offered more clinical trial information, highlighting the need for standardized data and databases.

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Personalizing cancer medicine requires integrating scientific evidence, drug approvals, and treatment guidelines.
  • Next-generation sequencing (NGS) generates complex data that necessitates sophisticated interpretation tools.
  • Knowledge-based curation systems aim to assist medical oncologists in making evidence-based treatment decisions.

Purpose of the Study:

  • To evaluate and compare the evidence levels and clinical trial information provided by three knowledge-based curation systems: Watson for Genomics (WfG), QIAGEN Clinical Insight Interpret (QCII), and Oncomine knowledge-based reporter (OKR).
  • To assess the concordance of variant curation and evidence levels across these systems for solid cancer patients.

Main Methods:

  • Sequencing of 31 formalin-fixed paraffin-embedded solid tumor samples using the Oncomine Comprehensive Assay v3.
  • Identification of variants including nonsynonymous mutations, gene fusions, and copy number alterations using Ion reporter software.
  • Independent curation of identified variants using WfG, QCII, and OKR systems, followed by analysis of concordance and evidence levels.

Main Results:

  • A total of 58 nonsynonymous mutations, 2 gene fusions, and 12 copy number variants were detected and curated across the three systems.
  • The number of curated variants varied, with 51 out of 72 variants receiving curation in at least one system.
  • Evidence level concordance was moderate, ranging from 56.9% to 66.7% between system pairs. WfG provided a higher number of clinical trial matches.
  • Significant differences were observed in clinical trial matching, potentially due to variations in filtering processes and database content.

Conclusions:

  • Knowledge-based curation systems (WfG, OKR, QCII) can be valuable tools for supporting solid cancer treatment decisions.
  • Discrepancies in evidence levels, particularly concerning clinical trial information, were noted between the systems.
  • Standardizing filtering procedures and enhancing Japanese clinical trial databases are recommended for improved accuracy and utility.

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
314
Stereotype Content Model02:16

Stereotype Content Model

The Stereotype Content Model (SCM) was first proposed by Susan Fiske and her colleagues (Fiske, Cuddy, Glick & Xu, 2002; see also Fiske, 2012 and Fiske, 2017). The SCM specifies that when someone encounters a new group, they will stereotype them based on two metrics: warmth—or that group’s perceived intent, and how likely they are to provide help or inflict harm—and competence—or their ability to carry out that objective. Depending on the warmth-competence...
15.4K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
474
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
313
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes02:16

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
15.1K